Back to Top Skip to main content Skip to sub-navigation

WRNMMC expands innovation and opens new, permanent drive-thru pharmacy

Image of Military pharmacist, wearing a mask, looking at bags of prescriptions. Click to open a larger version of the image. Army Sgt. Tyson Boothe filling a patient’s prescription at Walter Reed National Military Medical Center’s new Prescription Drive-Thru Pick-up located in in the parking lot of building 85T near Gate 1 (North gate). (Photo by Sean Patten, WRNMMC.)

Recommended Content:

Research and Innovation | Combat Support | Public Health | Coronavirus | Pharmacy Operations Toolkit | Coronavirus and the COVID-19 Vaccine | Information for Patients: TRICARE Pharmacy Program

On Sept. 22, Walter Reed National Military Medical Center (WRNMMC) held a ribbon cutting ceremony celebrating the grand opening of a new Prescription Drive-Thru Pick-Up near Naval Support Activity Bethesda’s Gate 1 (North gate).

During the onset of the COVID-19 pandemic, pharmacy team at WRNMMC quickly made adjustments to pharmacy operations in order to support social distancing and patient convenience.

In this effort, a curbside pharmacy-pick-up was implemented at the America Building (Bldg. 19) pharmacy and allowed for prescription pick-up without having to enter a building. Taking note of the prescription pick-up’s popularity, the WRNMMC pharmacy team set out to improve on this idea.

The new Prescription Drive-Thru Pick-up will operate similarly as the curbside pharmacy pick-up. The pharmacy team believes the new location and building will enhance their patient’s experience.

“This new prescription drive-thru pick-up will be a better environment for staff; and a more convenient and satisfying experience for patients,” stated Navy Cmdr. Emily Zywicke, chief of WRNMMC Pharmacy Department. “The new Prescription Drive-Thru Pick-up requires the patient to activate their new or refill medication 24 hours in advance, by phone or via TRICARE Online. The patient may drive-thru the new pharmacy pick-up in the parking lot of building 85T and have their medications within minutes.”

At the ribbon cutting ceremony, hospital leadership celebrated the hard work the Pharmacy Team put into making the Prescription Drive-thru Pick-up a reality. WRNMMC Chief of Staff Army Col. Anthony Meador, and Director for Clinical Support Services Army Col. Kari McRae both made remarks in recognition of the pharmacy team’s efforts.

“The Pharmacy Team has demonstrated tremendous innovation,” said McRae. “They are not just a group of doers, they are also a group of thinkers,” she added.

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

6025.31

Policy

Military Medical Treatment Facility Pharmacy Operations

DODI 6200.03: Public Health Emergency Management within the Department of Defense

Policy

In accordance with DoD Directive (DoDD) 5124.02, this issuance: • Establishes policy, assigns responsibilities, and provides direction to ensure mission assurance and readiness for public health emergencies caused by all-hazards incidents. • Defines a public health emergency within the DoD to include the occurrence or imminent threat of an illness or health condition that poses a high probability of a significant number of deaths, serious or long-term disabilities, widespread exposure to an infectious or toxic agent, overwhelmed health care resources, or severe degradation of mission capabilities. • Provides DoD policy for management of public health emergencies, in accordance with DoD Instruction (DoDI) 6055.17, through integration with the DoD Emergency Management (EM) Program. • Outlines the public health emergency health powers, roles, and responsibilities of the military installation commander, including the authority for restriction of movement. • Details procedures for internal and external notifications of DoD-declared public health emergencies. • Clarifies the PHEM roles and responsibilities of the medical treatment facility (MTF) commander or director, the public health emergency officer (PHEO), and the medical emergency manager (MEM).

  • Identification #: N/A
  • Date: 11/25/2019
  • Type: Instructions
  • Topics: Public Health

3200.01

Policy

Research and Development (R&D) Enterprise Activity (EA)

<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.